Liberty Wealth Management LLC Halozyme Therapeutics, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$31.82 - $40.75 $9,546 - $12,225	-300 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $517,465 - $683,603	-13,323 Reduced 97.8%	300 $14,000
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $517,465 - $683,603	13,323 Added 4441.0%	13,623 $300,000
Q4 2020 Feb 09, 2021	BUY	$25.81 - $43.62 $7,743 - $13,086	300 New	300 $14,000

544

126M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.